Your trusted source for GLP-1 research, news, and patient insights.
8 posts in this category
LillyDirect offers self-pay prices and easy access, but a Senate report raises questions about steering + cost. See how it works and what to watch.
Lost weight on a GLP-1 and worried a new provider won’t approve? Here is what the FDA labels, the research, and Medicare’s $50 program actually say.
Starting July 1, 2026, Medicare Part D patients could get GLP-1s for $50/month. Here's who qualifies, what's covered, and what's still in motion.
Medicare covers Wegovy and Zepbound for $50/month starting July 2026. Learn who qualifies, what it costs, and how to prepare for the GLP-1 Bridge.
Learn how GLP-1 insurance coverage works, including prior authorization, appeals, step therapy, and patient responsibilities.
Prescription approved but insurance said no? Learn your next options for Wegovy, Ozempic, or Zepbound coverage and care.
See how states, Medicare, Medicaid, and employer plans are handling GLP-1 coverage changes in 2026 and what it means for your insurance.
Learn what’s changing in 2026 insurance plans for GLP-1 drugs and how to compare costs, coverage, and plan options to stay protected.
